Bayesian Capital Management, LP Bausch Health Companies Inc. Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
A detailed history of Bayesian Capital Management, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 21,600 shares of BHC stock, worth $165,888. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,600Holding current value
$165,888% of portfolio
0.02%Shares
11 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$267 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$226 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$203 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$120 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$99.8 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.78B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...